The seizures were not abstract warnings. They were hers.
In a moment of rare public candor, model and actress Cara Delevingne has named her addiction to GHB with clinical precision — the drug, the daily use, the seizures that became her body's final refusal. Speaking on a widely heard podcast, she offered not a redemption arc polished for public consumption, but a factual account of how dependency progresses regardless of privilege or visibility. Her disclosure arrives as a reminder that addiction does not negotiate with fame, and that speaking a thing plainly is sometimes the first act of surviving it.
- Delevingne was not using GHB occasionally — she was taking the central nervous system depressant every single day, a pattern that quietly escalated until her body intervened with seizures.
- Those neurological episodes were not metaphorical warnings but physical crises that forced an immediate reckoning, becoming the hinge point between her former life and the one she now has to construct.
- Rather than offering a softened recovery narrative, she named the substance, the frequency, and the consequences with a specificity rarely seen in celebrity disclosures about addiction.
- GHB remains largely absent from mainstream public health conversations despite its narrow margin between an active dose and a lethal one — her account may shift that silence.
- By making her addiction a matter of public record, Delevingne has both raised awareness and quietly removed the option of returning to the drug unnoticed — accountability as a survival strategy.
Cara Delevingne appeared on the "Call Her Daddy" podcast and did something uncommon among public figures: she described her addiction to GHB with specificity rather than abstraction. The drug was not a party-night indulgence. It was a daily fixture — woven into her routine until her body drew its own line.
What ended the pattern was not an intervention or a decision made in clarity. It was seizures — neurological events that were hers alone, not cautionary stories borrowed from someone else's experience. They became the dividing line between the life she had been living and the one she would need to build.
GHB occupies an unusual place in the landscape of dangerous substances. Colorless and odorless, it carries a dangerously narrow margin between effect and overdose, yet it rarely commands the public health attention given to opioids or alcohol. Delevingne's account — grounded in the realities of chronic use and its consequences — adds a visible, named face to a conversation that typically unfolds in medical literature or behind closed treatment doors.
That someone with her resources and access to support reached a point of daily dependency says something important about how addiction operates: it does not yield to wealth or fame. It simply progresses. By speaking plainly and publicly, Delevingne has made her struggle harder to quietly reverse — and that, perhaps, is precisely the point.
Cara Delevingne sat down on the "Call Her Daddy" podcast and did something few celebrities have done with such directness: she walked through the mechanics of her own addiction, naming the drug, the frequency, and the moment her body forced her to stop.
The drug was GHB—gamma-hydroxybutyrate, a central nervous system depressant that became a fixture of club culture in the 1990s and 2000s. Delevingne was taking it daily. Not occasionally at parties. Not experimentally. Daily. The model and actress, known for her work in films like "Suicide Squad" and her high-profile modeling career, had reached a point where the substance had become woven into her routine.
What stopped her was not willpower or intervention, but her own body's rebellion. She suffered seizures—terrifying episodes that served as a biological line she could not cross. The seizures were not abstract warnings or cautionary tales told by others. They were hers. They happened to her. And they became the hinge point between the life she was living and the one she would have to build next.
The decision to speak publicly about this on a major podcast represents a shift in how some celebrities approach their recovery narratives. Rather than offering a sanitized version—the struggle, the triumph, the lesson learned—Delevingne provided specificity. She named the substance. She acknowledged the daily use. She did not soften the account with metaphor or distance. The seizures were not a metaphorical wake-up call. They were neurological events that changed the trajectory of her life.
GHB is not a drug that typically dominates public health conversations the way opioids or alcohol do, despite its serious risks. It is colorless, odorless, and has a narrow margin between an active dose and a dangerous one. Overdose can cause loss of consciousness, respiratory depression, and death. Chronic use carries its own set of consequences, as Delevingne's experience illustrates. The seizures she experienced are consistent with the drug's known effects on the central nervous system, particularly during withdrawal or as a result of prolonged use.
By speaking about her addiction in concrete terms, Delevingne has added a visible face to a conversation that often happens in medical literature or in the private spaces of treatment facilities. She has also, perhaps unintentionally, created a data point in the broader discussion about how party drugs move through culture and what happens when they move from occasional use to daily dependency. The fact that someone with her resources, visibility, and access to help reached a point of daily GHB use suggests something about how addiction operates—it does not discriminate based on fame or wealth. It simply progresses.
What comes next for Delevingne is the ongoing work of sobriety, a project that has no finish line. The seizures stopped her. Now she has to build a life that does not require the thing that nearly killed her. By naming it publicly, she has also made it harder to return to it quietly. That may be the point.
Notable Quotes
Delevingne revealed she was taking GHB daily before suffering seizures that prompted her recovery— Cara Delevingne, on "Call Her Daddy" podcast
The Hearth Conversation Another angle on the story
When you say she was taking it daily, what does that actually mean for someone's life? How does that work logistically?
It means the drug became infrastructure. Not something you do at a party—something you do before breakfast, before work, before sleep. It's the difference between using and being dependent. The daily use is what makes the seizures possible.
And the seizures—were those a surprise, or had there been warning signs?
The source doesn't specify, but seizures from GHB are a known risk of chronic use. They're not subtle. They're terrifying. That's what stopped her.
Why does it matter that she's talking about this now, publicly?
Because GHB doesn't get the attention that opioids or alcohol do, even though it's dangerous. When someone with her visibility names it, it becomes real to people who might otherwise think it's just a club drug with no real consequences.
Do you think she's trying to help others, or is this more personal—just telling her story?
Probably both. But the effect is the same either way. She's made it impossible to pretend this is a small problem or something that only happens to certain kinds of people.
What happens now?
She stays sober. That's the work. The seizures were the crisis. Sobriety is the long project.